Primary objectivesAs our primary efficacy objective, we will compare procedural success rate between the two groups, which is defined as defined as the successful insertion of both arterial and venous cannulas and subsequent initiation of ECMO-flow…
ID
Source
Brief title
Condition
- Heart failures
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Main study parameter/endpoint
Primary efficacy endpoint: procedure success rate, defined as the successful
insertion of both arterial and venous cannulas within 3 attempts and subsequent
successful initiation of ECMO-flow
Primary safety objective: is a composite of cannulation-associated adverse
events during cannulation, during ECMO and after ECMO decannulation, including:
o Vascular complications, defined as development of a false aneurysm,
dissection, perforation or another type of vascular damage
o Cannulation site bleeding and other major bleeding (BARC type 2 and above)
o The development of limb ischemia requiring fasciotomy or amputation
o Local infections, defined as a wound culture-proven infection
o Systemic infections, defined as blood culture-proven infection
Secondary outcome
Secondary study parameters/endpoints
Separate analysis of the components of the composite endpoint:
o Vascular complications, which is defined as the development of a false
aneurysm, dissection, perforation or another type of vascular damage
o Cannulation site bleeding and other major bleeding (BARC type 2 and above)
o The development of limb ischemia requiring fasciotomy or amputation
o Local infections, defined as a wound culture-proven infection
o Systemic infections, defined as blood culture-proven infection
As well as:
- Thirty-day mortality
- Cross-over rate due to failed cannulation
- Procedure time, defined as time from first puncture/incision to the moment of
ECMO-flow initiation
- Number of attempts with successful puncture, but failure to advance the wire
- Number of failed percutaneous attempts, defined as wire insertion without
successful cannulation
Background summary
the traditional method for femoral cannulation in the setting of veno-arterial
extracorporeal membrane oxygenation (VA ECMO) is a surgical approach.
Techniques for percutaneous insertion have improved drastically over the recent
years, and this less invasive procedure has been associated with a lower
complication rate. Therefore, it has increasingly become first-line strategy in
ECMO-centers worldwide.
Study objective
Primary objectives
As our primary efficacy objective, we will compare procedural success rate
between the two groups, which is defined as defined as the successful insertion
of both arterial and venous cannulas and subsequent initiation of ECMO-flow. A
percutaneous approach is considered feasible when a first line success rate of
75% is reached. Our primary safety objective is the comparison of a composite
of cannulation-associated adverse events, including vascular complications,
bleeding, limb ischemia and cannulation-site as well as systemic infection. A
percutaneous approach is considered safe when the cannulation-associated
adverse event rate is equal in both groups, or lower in the percutaneous group.
Secondary objectives
As our secondary efficacy objective, we will compare procedural
characteristics, such as number of attempts (including the number of failed
attempts), cross-over rates and procedure duration. Our secondary safety
objective consists of the comparison of each individual component of the
composite safety endpoint, as well as thirty-day mortality, between the two
groups.
Study design
Two-center randomized controlled trial, open
Intervention
Percutaneous insertion of ECMO cannulas
Study burden and risks
Patients presenting with an indication for VA ECMO are critically ill and as
such, have a dismal prognosis. As outlined above, a selected group of patients
is eligible for this treatment modality to potentially improve outcomes.
For this study, these patients are randomized to either surgical implantation
of VA ECMO (standard of care), or percutaneous implantation (intervention
group). We expect complication rate in the intervention group to be similar or
lower, when compared to standard of care.
This study concerns a critically ill patient population. As a percutaneous
technique may be employed faster and as it may also be associated with a lower
complication rate, the potential benefit for this patient population outweighs
the known potential risks. Importantly, both surgical and percutaneous
implantation methods are widely established, standard of care interventions.
Risks associated with either procedure are deemed relatively low
Meibergdreef 9
Amsterdam 1105AZ
NL
Meibergdreef 9
Amsterdam 1105AZ
NL
Listed location countries
Age
Inclusion criteria
1. Age above 18
2. Indication for VA ECMO support (according to international guidelines and as
discussed in our multidisciplinary team)
3. (Deferred) informed consent by proxy
Exclusion criteria
Patients who are not suitable for undergoing VA ECMO support according to our
standard of practice. In addition, patients undergoing central cannulation in
the operating theatre, are excluded from participation, as well as patients
with no peripheral vascular access
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL82403.018.22 |